We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Metallus
MTUS
$687M
| $27.6K | 0.01% |
1,477
| – | – |
2019 Q4
26 quarters
|
|
227
Gilead Sciences
GILD
$207B
| $27.4K | 0.01% |
217
+51
| +31% | +$6.72K |
2019 Q4
26 quarters
|
|
228
InfuSystem Holdings
INFU
$273M
| $27K | 0.01% |
2,800
| – | – |
2024 Q2
8 quarters
|
|
229
O'Reilly Automotive
ORLY
$72.3B
| $26.9K | 0.01% |
292
| – | – |
2022 Q1
17 quarters
|
|
230
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$11B
| $26.7K | 0.01% |
+100
| New | +$16.8K |
2026 Q2
0 quarters
|
|
231
Insmed
INSM
$25.1B
| $26.7K | 0.01% |
250
| – | – |
2019 Q4
26 quarters
|
|
232
First Trust Health Care AlphaDEX Fund
FXH
$1.15B
| $25.7K | 0.01% |
210
| – | – |
2022 Q1
17 quarters
|
|
233
Sweetgreen
SG
$1.43B
| $25.7K | 0.01% |
2,914
| – | – |
2025 Q3
3 quarters
|
|
234
Corning
GLW
$91.4B
| $25.5K | 0.01% |
100
+45
| +82% | +$8.19K |
2019 Q4
26 quarters
|
|
235
Ardelyx
ARDX
$724M
| $25.4K | 0.01% |
4,985
| – | – |
2024 Q1
9 quarters
|
|
236
McDonald's
MCD
$196B
| $25.1K | 0.01% |
93
+15
| +19% | +$4.3K |
2019 Q4
26 quarters
|
|
237
MGM Resorts International
MGM
$8.18B
| $23.9K | 0.01% |
500
| – | – |
2019 Q4
26 quarters
|
|
238
NRG Energy
NRG
$18.6B
| $23.6K | 0.01% |
162
+1
| +0.6% | +$144 |
2019 Q4
26 quarters
|
|
239
US Global Jets ETF
JETS
$903M
| $23.4K | 0.01% |
704
| – | – |
2021 Q1
21 quarters
|
|
240
Viper Energy
VNOM
$7.84B
| $23K | 0.01% |
542
+7
| +1% | +$323 |
2022 Q1
17 quarters
|
|
241
Green Dot
GDOT
$697M
| $22.3K | 0.01% |
1,650
| – | – |
2025 Q4
2 quarters
|
|
242
Zeta Global
ZETA
$7.79B
| $21.8K | 0.01% |
1,110
+1,000
| +909% | +$18.5K |
2025 Q4
2 quarters
|
|
243
Polaris
PII
$3.59B
| $21.4K | 0.01% |
313
-8
| -2% | -$515 |
2025 Q1
5 quarters
|
|
244
iShares Dow Jones US ETF
IYY
$2.88B
| $21.4K | 0.01% |
117
| – | – |
2019 Q4
26 quarters
|
|
245
Netflix
NFLX
$264B
| $20.7K | 0.01% |
290
| – | – |
2021 Q3
19 quarters
|
|
246
iShares US Healthcare ETF
IYH
$4.63B
| $20.6K | 0.01% |
308
+1
| +0.3% | +$63 |
2020 Q2
24 quarters
|
|
247
Qualcomm
QCOM
$177B
| $20.5K | 0.01% |
111
+46
| +71% | +$8.6K |
2019 Q4
26 quarters
|
|
248
Tectonic Therapeutic
TECX
$403M
| $20.2K | 0.01% |
587
| – | – |
2025 Q4
2 quarters
|
|
249
Butterfly Network
BFLY
$1.7B
| $20.1K | 0.01% |
2,390
| – | – |
2025 Q3
3 quarters
|
|
250
Global X Robotics & Artificial Intelligence ETF
BOTZ
$2.91B
| $19.9K | 0.01% |
525
| – | – |
2021 Q2
20 quarters
|
|
Similar funds
BOC
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.